Applied Molecular Transport Inc.
NASDAQ:AMTI
Applied Molecular Transport Inc.
NASDAQ:AMTI
Price:
0.263 USD
Market Closed
Updated:
May 20, 2024
Applied Molecular Transport Inc.
Accumulated Depreciation
|
Applied Molecular Transport Inc.
Accumulated Depreciation Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Applied Molecular Transport Inc.
NASDAQ:AMTI
|
Accumulated Depreciation
-$9m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Accumulated Depreciation
-$6.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Applied Molecular Transport Inc.'s Accumulated Depreciation?
Accumulated Depreciation
-9m
USD
-9m
USD
Based on the financial report for Dec 31, 2022, Applied Molecular Transport Inc.'s Accumulated Depreciation amounts to -9m USD.
What is Applied Molecular Transport Inc.'s Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-74%
-74%
Over the last year, the Accumulated Depreciation growth was 5%. The average annual Accumulated Depreciation growth rates for Applied Molecular Transport Inc. have been -74% over the past three years .
You don't have any saved screeners yet
